FDA
Ibandronate Sodium
The FDA lists this product in 18 strengths and forms.
Composition
- Active ingredients
- IBANDRONATE SODIUM EQ 3MG BASE/3ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- IBANDRONATE SODIUM EQ 3MG BASE/3ML · InjectableANDA202671-001 · Prescription
- IBANDRONATE SODIUM EQ 3MG BASE/3ML · InjectableANDA204222-001 · Prescription
- IBANDRONATE SODIUM EQ 3MG BASE/3ML · InjectableANDA205332-001 · Prescription
- IBANDRONATE SODIUM EQ 150MG BASE · TabletANDA078998-001 · Prescription
- IBANDRONATE SODIUM EQ 3MG BASE/3ML · InjectableANDA203987-001 · Discontinued
- IBANDRONATE SODIUM EQ 150MG BASE · TabletANDA078948-001 · Prescription
- IBANDRONATE SODIUM EQ 3MG BASE/3ML · InjectableANDA202235-001 · Discontinued
- IBANDRONATE SODIUM EQ 150MG BASE · TabletANDA078996-001 · Discontinued
- IBANDRONATE SODIUM EQ 150MG BASE · TabletANDA078997-001 · Prescription
- IBANDRONATE SODIUM EQ 150MG BASE · TabletANDA079003-001 · Discontinued
- IBANDRONATE SODIUM EQ 150MG BASE · TabletANDA204502-001 · Prescription
At a glance
- Brand name
- Ibandronate Sodium
- Route
- Intravenous
- Dosage form
- Injectable
- Applicant
- Nang Kuang Pharm Co
- Status
- Discontinued
- FDA approval
- 16 Jun 2021
- Application
- ANDA204329-001